A mixed-methods study of 456 people with depressive symptoms found that perceived need was a key predictor of professional ...
Dr. Penelope Markham, BioVie’s Senior Vice President and Program Lead for Long COVID, will share results from the Company’s Phase 2 ADDRESS-LC trial evaluating bezisterim for the treatment of the ...
Alethios, the software platform delivering research infrastructure for human health, today launched a comprehensive suite of ...
Why can't the discernment of interviewers be verified?The task of reading through resumes is considered a burden for ...
As financial services scale their operations in cloud-native environments, the volume, complexity, and velocity of consumer data are testing ...
The 36-page report, released Tuesday, looks at how the province’s Department of Public Works decides what stretches of roads ...
According the the report, the province hasn't updated it's infrastructure deficit estimate since 2009.
More information doesn’t always mean better information. Today, golfers have access to more information than ever before. The web ...
Self-supervised learning creates training targets from the structure of unlabeled data, allowing models to learn ...
Hello. I am Imoto, a coach specializing in career lost-and-found.I develop and operate the 'Neuro-Physical Manual Diagnosis (Free)' to help people who are caught in the cycle of busyness and spinning ...
BioVie Inc. announced the presentation of results from the Phase 2 ADDRESS-LC study (NCT06847191) evaluating bezisterim (NE3107) in patients with Long COVID at the 151st Annual Meeting of the American ...
In AD, BioVie has conducted Phase 2 and Phase 3 trials. Preliminary data from these trials suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results